Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹1,020 Cr
Revenue (TTM)
₹448 Cr
Net Profit (TTM)
₹41 Cr
ROE
21.4 %
ROCE
29.6 %
P/E Ratio
25.2
P/B Ratio
3.9
Industry P/E
44.5
EV/EBITDA
11.9
Div. Yield
2 %
Debt to Equity
0.1
Book Value
₹32.1
EPS
₹4.9
Face value
10
Shares outstanding
82,054,823
CFO
₹935.13 Cr
EBITDA
₹466.76 Cr
Net Profit
₹232.94 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
GPT Healthcare
| -11.6 | -4.1 | -11.2 | -8.5 | -- | -- | -- |
|
BSE Healthcare
| -1.7 | -1.1 | -1.9 | 7.5 | 25.6 | 15.6 | 10.7 |
|
Company
|
2025
|
|---|---|
|
GPT Healthcare
| -23.4 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
GPT Healthcare
|
124.0 | 1,019.9 | 447.6 | 40.5 | 12.6 | 16.2 | 25.2 | 3.9 |
| 230.4 | 3,655.3 | 1,041.9 | 96.4 | 12.0 | 11.5 | 37.8 | 3.1 | |
| 662.0 | 34,286.7 | 4,461.2 | 397.5 | 13.4 | 9.1 | 104.9 | 7.5 | |
| 434.0 | 13,736.8 | 1,976.2 | 160.7 | 14.1 | 6.7 | 109 | 7.0 | |
| 570.0 | 8,470.7 | 2,478.2 | 24.7 | 8.4 | 4.2 | 447 | 6.3 | |
| 1,282.0 | 8,393.4 | 1,433.4 | 188.7 | 17.4 | 13.8 | 44.5 | 5.6 | |
| 5,299.2 | 5,798.5 | 1,529.9 | 235.8 | 21.2 | 20.7 | 24.6 | 4.6 | |
| 201.1 | 8,679.7 | 1,393.6 | 213.2 | -- | 22.1 | 42.3 | 4.6 | |
| 1,123.9 | 11,410.7 | 1,613.3 | 259.9 | 23.0 | 17.3 | 44.3 | 7.2 | |
| 673.3 | 6,489.5 | 1,089.4 | 165.1 | 17.4 | 10.2 | 38.8 | 3.7 |
4 min read•By Satyajit Sen
GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants;... laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurology; neurosurgery; pediatrics; neonatology; robotic-assisted surgery; bariatric surgery; hematology; psychology; dermatology; and ENT services. It also operates clinics and pharmacies; provides academic and diagnostic services; and sale of pharmaceutical products. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd. Read more
Incorporated
1989
Chairman
Om Tantia
Managing Director
Om Tantia
Headquarters
Kolkata, West Bengal
Website
Looking for more details about GPT Healthcare Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
The share price of GPT Healthcare Ltd is ₹124.03 (NSE) and ₹124.30 (BSE) as of 18-Mar-2026 IST. GPT Healthcare Ltd has given a return of -8.5% in the last 1 years.
The P/E ratio of GPT Healthcare Ltd is 25.16 times as on 18-Mar-2026, a 43 discount to its peers’ median range of 44.50 times.
The P/B ratio of GPT Healthcare Ltd is 3.88 times as on 18-Mar-2026, a 41 discount to its peers’ median range of 6.63 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
24.11
|
4.86
|
|
2024
|
30.31
|
6.63
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of GPT Healthcare Ltd are Rs 185.00 and Rs 119.34 as of 19-Mar-2026.
GPT Healthcare Ltd has a market capitalisation of ₹ 1,020 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in GPT Healthcare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹2.48
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.